Our goal is to achieve breakthroughs in sarcoma research that help improve patient outcomes, and ultimately lead to a cure.
The next meeting will be held: Saturday, November 11, 2017
8:00 am - 10:00 am, HST
Grand Wailea Resort, Room: Haleakala 1; Maui, Hawaii
ZHENFENG DUAN, PHD
Massachusetts General Hospital
Dissecting CDK11 kinase pathway in osteosarcoma
JONATHAN FLETCHER, MD
ADRIÁN MARIÑO-ENRIQUEZ, MD, PHD
Brigham & Women’s Hospital
Biomarkers for Dystrophin-deficiency in sarcoma
CHARLES KELLER, MD
Oregon Health & Science University
DAVID LANGENAU, PHD
Massachusetts General Hospital
GSK3-beta inhibitors for relapsed rhabdomyosarcoma
DAVID KIRSCH, MD, PHD
REBECCA DODD, PHD
Duke University Medical Center
Translating discoveries from a mouse model into metastatic biomarkers
STEPHEN LESSNICK, MD, PHD
SUNIL SHARMA, MD
University of Utah Huntsman Cancer Center
Epigenetic targeting of LSD1 as a therapeutic strategy for Ewing sarcoma
KEBIN LIU, PHD
Georgia Regents University
RAPHAEL POLLOCK, MD, PHD
Ohio State University
Combined radiosensitization and T cell immunotherapy for metastatic sarcoma
LAURENCE BAKER, DO
University of Michigan
Can heart disease be predicted in young survivors of osteosarcoma using morphomics and/or coronary artery calcium scores?
DAVID KIRSCH, MD, PHD
YVONNE MOWERY, MD, PHD
Duke University Medical Center
Mechanisms that regulate sarcoma response to immune checkpoint Inhibition of PD1
SETH POLLACK, MD
Fred Hutchinson Cancer Research Center
Designing improved T-cell therapies for sarcoma patients
